Literature DB >> 10851368

Do transient ischemic attacks have a neuroprotective effect?

J Moncayo1, G R de Freitas, J Bogousslavsky, M Altieri, G van Melle.   

Abstract

OBJECTIVE: To determine whether TIAs have a neuroprotective effect.
BACKGROUND: Ischemic tolerance or preconditioning, which protects the brain against stroke, has been demonstrated in animal models of cerebral ischemia. Because TIA may represent a clinical model of ischemic tolerance, patients with TIA before cerebral infarction (CI) may therefore have a better outcome than patients without TIA before CI.
METHODS: A total of 2,490 patients admitted consecutively to a primary care center for first-ever CI in the anterior circulation were divided into two groups on the basis of the presence or absence of prior ipsilateral TIAs. Duration of TIA was classified into three groups (<10 minutes, 10 to 20 minutes, and >20 minutes). The severity of the neurologic picture on admission and functional disability after stroke were compared between patients with and without TIAs.
RESULTS: A total of 293 (12%) of the 2,490 patients had prior ipsilateral TIAs before CI. Risk factors did not differ between patients with or without TIAs, whereas the topography and etiology of ischemic stroke did differ (p < 0.001). Patients without prior TIAs had a more severe clinical picture on admission, with a greater reduction of consciousness (p = 0.009). Patients with previous TIAs had a more favorable outcome than those without TIAs (67% versus 58%, p = 0.004). After adjustment for confounding variables, TIAs lasting 10 to 20 minutes were still associated with a favorable outcome (odds ratio, 1.98; 95% confidence interval, 1.27 to 3.08; p = 0.002). The interval between TIA and CI influenced the outcome (p = 0.007).
CONCLUSIONS: This study suggests that ischemic tolerance may play a role in patients with ipsilateral TIAs before CI, allowing better recovery from a subsequent ischemic stroke.

Entities:  

Mesh:

Year:  2000        PMID: 10851368     DOI: 10.1212/wnl.54.11.2089

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  75 in total

Review 1.  The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling.

Authors:  B McLaughlin
Journal:  Apoptosis       Date:  2004-03       Impact factor: 4.677

2.  Lymphocyte cell kinase activation mediates neuroprotection during ischemic preconditioning.

Authors:  Ok-Nam Bae; Krishnamurthy Rajanikant; Jiangyong Min; Jeremy Smith; Seung-Hoon Baek; Kelsey Serfozo; Siamak Hejabian; Ki Yong Lee; Mounzer Kassab; Arshad Majid
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

Review 3.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 4.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

Review 5.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

Review 6.  Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients.

Authors:  Bethann McLaughlin; Jeff M Gidday
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

7.  Preconditioning the human brain: practical considerations for proving cerebral protection.

Authors:  Sebastian Koch
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

Review 8.  Clinical application of preconditioning and postconditioning to achieve neuroprotection.

Authors:  Cameron Dezfulian; Matthew Garrett; Nestor R Gonzalez
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

Review 9.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

10.  Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.

Authors:  Eugenia B Manukhina; H Fred Downey; Xiangrong Shi; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.